Drug intelligence / Profile preview

Valpromide

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral
01

Overview

Valpromide is a carboxamide derivative of valproic acid and acts as a prodrug for valproic acid. It is used primarily in the treatment of epilepsy and as an adjunct therapy for psychomotor agitation, depression, and manic episodes associated with bipolar disorder. After oral administration, it is rapidly metabolized (about 80%) to valproic acid but also possesses intrinsic anticonvulsant activity. Its mechanism of action involves increasing GABA levels in the brain and altering neuronal membrane conductance, contributing to its antiepileptic and mood-stabilizing effects. Valpromide inhibits liver microsomal epoxide hydrolase much more potently than valproic acid, which can lead to significant drug interactions (notably with carbamazepine). It may provide more stable plasma levels than other forms of valproate but shares similar safety concerns during pregnancy[1][2][4][5][8].

Brand names
Depamide
Other names
ValpromidaDipropylacetamide
02

Targets

NaV (Voltage-gated sodium channels)EPHX1 (Epoxide hydrolase 1)ABAT (4-aminobutyrate aminotransferase)

Beyond the preview

Go deeper on Valpromide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valpromide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call